Table 2. Concordance between tumor HPV DNA and anti-HPV antibodies.
Antibodies | HPV-16 DNA negative |
HPV-16 DNA positive |
κ statistic (95% CI) |
---|---|---|---|
n = 106 (%) | n = 37 (%) | ||
HPV-16 VLP | |||
Negative | 82 (77) | 14 (38) | 0.36 (0.20-0.53) |
Positive | 24 (23) | 23 (62) | |
HPV-16 E6 | |||
Negative | 103 (97) | 12 (32) | 0.70 (0.56-0.84) |
Positive | 3 (3) | 25 (68) | |
HPV-16 E7 | |||
Negative | 103 (97) | 13 (35) | 0.68 (0.54-0.82) |
Positive | 3 (3) | 24 (65) | |
HPV-16 E6 and/or E7 | |||
Negative | 101 (95) | 9 (24) | 0.74 (0.61-0.87) |
Positive | 5 (5) | 28 (76) |
NOTE: HPV DNA results from paraffin-embedded tissues available for 145 patients at the time of analysis; two cases were excluded because their tumors were detected with HPV-33.